Jefferies Group LLC Neurocrine Biosciences Inc Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $1.44 Million - $1.88 Million	-19,865 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$79.65 - $106.22 $552,930 - $737,379	-6,942 Reduced 25.9%	19,865 $1.69 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $552,930 - $737,379	-6,942 Reduced 25.9%	19,865 $1.69 Million
Q3 2021 Sep 21, 2023	SELL	$86.18 - $99.03 $1.27 Million - $1.46 Million	-14,736 Reduced 35.47%	26,807 $2.57 Million
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $1.27 Million - $1.46 Million	-14,736 Reduced 35.47%	26,807 $2.57 Million
Q2 2021 Sep 21, 2023	BUY	$89.43 - $102.27 $579,774 - $663,016	6,483 Added 18.49%	41,543 $4.04 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $579,774 - $663,016	6,483 Added 18.49%	41,543 $4.04 Million
Q1 2021 Sep 21, 2023	BUY	$87.57 - $119.4 $3.07 Million - $4.18 Million	35,001 Added 59323.73%	35,060 $3.41 Million
Q1 2021 May 14, 2021	BUY	$87.57 - $119.4 $3.07 Million - $4.18 Million	35,001 Added 59323.73%	35,060 $3.41 Million
Q4 2020 Sep 21, 2023	BUY	$86.91 - $108.33 $5,127 - $6,391	59 New	59 $5,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $3 Million - $3.74 Million	-34,518 Reduced 99.83%	59 $6,000
Q3 2020 Nov 13, 2020	BUY	$96.16 - $135.15 $2.63 Million - $3.69 Million	27,327 Added 376.92%	34,577 $3.33 Million
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $2.37 Million - $3.62 Million	-27,796 Reduced 79.31%	7,250 $885,000
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $1.22 Million - $1.85 Million	-16,233 Reduced 31.66%	35,046 $3.03 Million
Q4 2019 Feb 13, 2020	SELL	$86.8 - $118.57 $8.08 Million - $11 Million	-93,066 Reduced 64.47%	51,279 $5.51 Million
Q3 2019 Nov 13, 2019	BUY	$83.82 - $101.5 $6.22 Million - $7.53 Million	74,173 Added 105.7%	144,345 $13 Million
Q2 2019 Aug 14, 2019	BUY	$72.24 - $91.27 $4.88 Million - $6.17 Million	67,615 Added 2644.31%	70,172 $5.93 Million
Q1 2019 May 15, 2019	SELL	$69.31 - $91.53 $3.72 Million - $4.91 Million	-53,689 Reduced 95.45%	2,557 $225,000
Q4 2018 Feb 14, 2019	BUY	$68.32 - $124.36 $213,363 - $388,376	3,123 Added 5.88%	56,246 $4.02 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $1.76 Million - $2.23 Million	-17,755 Reduced 25.05%	53,123 $6.53 Million
Q2 2018 Aug 14, 2018	BUY	$75.3 - $105.99 $4.96 Million - $6.98 Million	65,878 Added 1317.56%	70,878 $6.96 Million
Q1 2018 May 15, 2018	SELL	$75.88 - $92.43 $141,743 - $172,659	-1,868 Reduced 27.2%	5,000 $415,000
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $205,967 - $273,039	3,519 Added 105.08%	6,868 $533,000
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $160,651 - $205,226	3,349	3,349 $205,000

Others Institutions Holding NBIX

# of Institutions

638

Shares Held

93.8M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$2.15 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.52 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$782 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$391 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$283 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.5B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account